Upload
others
View
9
Download
0
Embed Size (px)
Citation preview
CHAPTER III
RELATIONSHIP MARKETING – ROLE OF MEDICAL
REPRESENTATIVES, DOCTORS AND PHARMA COMPANIES
3.1 INTRODUCTION
In this chapter an attempt has been made to doctors relationship with
pharma company. Pharma company is concerned, its marketing channel
requires a minimum of two parties. In particular, as far as manufacturer of
prescription drugs is concerned, the law requires that at least one
intermediary stands between the manufacturer and the customer, that is the
doctors. It is illegal for the manufacturer to sell prescription drugs directly to
the patient. Therefore, the doctor plays a pivotal role in pharmaceutical
marketing channels and indeed in pharmaceutical marketing activity, as a
whole. Without the prescription of a doctor no ethical drug can be dispensed
by the retailer to the patient. The doctor is the decision maker and his role in
the distribution channel is vitally important to promote the sale of
pharmaceutical products. Hence, an attempt has been made to analyse the
relationship marketing with the doctors, medical representatives and pharma
company. The analysis has been classified into the following heads:
82
(i) Concept of Relationship marketing
(ii) Organizational prospective from the Doctors
(iii) Doctors prospective from the pharmaceutical company
(iv) Relationship between Medical representatives, and Doctors
(v) Relationship between senior managers and Doctors
(vi) Dimension-wise comparison between doctors and medical
representatives perceptions on relationship with pharma
company.
3.2 RELATIONSHIP MARKETING
Marketing is a social and managerial process by which individuals
and groups obtain what they need and want through creating, offering, and
exchanging products of value with others1.
This definition of marketing rests on the following core concepts:
needs, wants and demands; products (goods, services and ideas); value, cost,
and satisfaction; exchange and transactions; relationships and networks;
markets; and marketers and prospects. These concepts are illustrated in the
Chart.
1 Philip Kotler, Marketing Management, 13
th Edition Prentice Hall of India,
New Delhi, 2009, p.14.
83
CHART 3.1
THE CORE CONCEPTS OF MARKETING
Needs, Wants and Demands
Products
(goods, services and ideas)
Value, Cost and Satisfaction
Exchange and Transactions
Relationship and Networks
Markets
Markets and Prospects
84
Marketing is the process of planning and executing the conception,
pricing, promotion, and distribution of ideas, goods, and services to create
exchanges that satisfy individual and organizational goals2.
Relationship marketing is the practice of building long-term satisfying
relations with key parties –customers, suppliers, distributors—in order to
retain long term preference and business3.
Relationship marketing is the focus of marketing activities on
establishing, developing and maintaining cooperative, long-term
relationships. Firms today are devoting considerable attention to building
sustainable competitive advantages by developing and maintaining close
cooperative relationships with a limited set of suppliers, customers and
channel members. The attractiveness of this approach for building
competitive advantage has led many marketing scholars to suggest that
relationship marketing is the new marketing paradigm.
2Peter D. Bennett, Dictionary of Marketing Terms, 2
nd Edition, Chicago:
American Marketing Association, 1995.
3 Martin Christopher, Adrian Payne, David Ballantyne and Regis Mckenna,
Relationship Marketing, Reading MA: Addison Wesly, 1991, Relationship Marketing:
Bringing Quality, Customer Service and Marketing Together, Oxford, England
Butterworth Heinemann, 1991.
85
Relationship marketing appears to be the backbone of the pharma
company, as evidenced by the continual increases in the number of Medical
representatives.
3.3 ORGANIZATIONAL PROSPECTIVE FROM THE DOCTORS
THROUGH RELATIONSHIP MANAGEMENT
The ultimate aim of relationship marketing in pharmaceutical is, to get
prescription from the doctors and the purpose is to treat the patient’s illness.
In the pharma company prescription can be defined as follows:
A prescription has many functions both apparent and latent.
The different definitions of a prescription are:
“Art of compounding defines a prescription as “an order written by
the doctors, dentist, veterinarian or any other licensed practitioner directing
the pharmacist to compound and dispense medication for a patient and
usually accompanied by directions for its administration or use”.
“Prescription”, in its verb form may also refer to the act of issuing the
order by the licensed practitioner. A doctor may “prescribe” rest, diet and
exercise without giving any medicines on, certain occasions”.
86
“Dictionary definition of “prescription” may refer to the directions for
administration”.
In deed of “prescription” serves a broad spectrum of functions. The
most familiar functions of a prescription are that it serves as:
A means of communication between the doctors, patient and
pharmacist.
Legal authorization for dispensing “legend” drugs.
Therapeutic record source.
A method of therapy.
A means of clinical trial.
Thus, we can see that “prescription” is more than an exchange
process. For quite some time, prescriptions have been used to study
treatment patterns and predict and analyze markets for various therapeutic
categories in a number of countries.
In today's highly competitive pharmaceutical marketing arena,
discerning marketers are increasingly concentrating on studying prescription
trends and the prescribing behaviour of doctors.
87
The organization expectations from the doctors through relationship
management are:
To generate and increase good numbers of prescription.
To generate and increase good numbers of prescriber base.
Brand establishment.
Satisfying customers need and developing Loyal Customers.
Growth in sales.
To establish the company as well as product image at market place.
Profitability and
Service to human welfare.
(i) To Generate and Increase Good Number of Prescription
In pharma company doctors are the back bone of the their business. In
this context, their major objective is to generate more number of
prescriptions from each and every doctor whom they are meeting. Through
relationship marketing, they want to increase demands for their brands
obtained through the patronage of the doctors.
88
(ii) To Generate and Increase the Prescriber-base
In relationship marketing, all Pharma companies would like to
increase their prescriber-base through various marketing activities by their
Medical representatives. The steady increase in the number of doctor’s
prescriptions enhances the sale value of their medicine.
(iii) Brand Establishment
Through relationship marketing, they can popularize their brands by
increasing the number of prescriptions and prescribers base. Thereby they
get good business returns as well as better brand image at market place.
(iv) Satisfying Customers Need and Developing Loyal Customers
Relationship activities, if successful in propitiating the doctors in all
aspects, he will recommend their company brands continuously and will
become Loyal customers leading to good business returns.
(v) Growth in Sales
If a company develops a large number of Loyal customers for their
brands, automatically the sales of that brand will go up.
89
(vi) To Establish the Company as well as Product Image at Market
Place
Through relationship marketing pharmaceutical companies want to
establish their company image as well as products image by increasing sales
volume at market places.
(vii) Profitability
A business organization's ultimate aim is to make profit. Through
relationship marketing only they can achieve their goals.
(viii) Service to Human Welfare
In general all pharmaceuticals products should help the human beings'
welfare. Most of the pharmaceuticals companies market good quality
products with affordable prices to serve the human needs.
All these activities happen only through doctors’ relationship
marketing.
90
3.4 DOCTORS PROSPECTIVE FROM THE PHARMA COMPANIES
The following factors are very vital expectation from the Pharma
companies by doctors.
Scientific Information and Educations
Quality products
Solution to their Patients problems
Patients' benefits
Regular visits by Medical representatives and senior managers
Satisfying their needs or Sponsorship
(i) Scientific Information and Education
Doctor’s practice in today's environment, scientific information and
education are vital one to update their knowledge, thereby they will be able
to serve their patients in a better way. So all doctors are expecting good
scientific information (like leave behind literatures, reprints, clinical trails
data) or scientific education like Continuing medical education and
Continuing Technical education (like laser, cosmetic surgery), from the
pharmaceutical companies.
91
(ii) Quality Products
Generally all doctors expect good quality products and product range
to satisfy their patients' need from the pharmaceutical companies.
(iii) Solution to their Patients' Problems
Doctors always look forward to good practical solution from the
pharmaceuticals companies to solve their patients' problems through
innovative products or services (like patients' education programme).
(iv) Patients Benefits
Doctors are more keen on patients' welfare. So they expect from
pharmaceuticals companies to market the products that give good results
quickly at affordable prices.
(v) Regular Visits by Medical Representatives and Senior Managers
Doctors always look forward to the visit of the medical
representatives and managers to their clinics or hospitals at regular intervals.
92
(vi) Satisfying Their Needs or Sponsorship
Doctors are expecting good support from pharmaceuticals companies
to satisfy their clinics or hospitals or personal needs or sponsorship to attend
national and international conferences.
These are the expectations from the pharmaceuticals companies by
Doctors.
The doctors consider two major factors while they prescribe the drugs
which are scientific benefit or commercial and both benefits. Scientific
information includes editorial contents of medical journals, articles
published in medical journals, other doctors' experience, clinical
pharmacologists and research publications, product information
monographs, and literature published by pharmaceutical companies,
advertisements in medical journals detailed talks by medical representatives,
clinical trail reports, seminars and symposia conducted by drug companies.
Commercial benefits include products offer, clinical supports, Gifts
and sponsorship.
93
3.5 RELATIONSHIP BETWEEN MEDICAL REPRESENTATIVES
AND DOCTORS
Medical Representatives plays a key role in the formation of long-
term relationship between company and Doctors. In this context, personal
selling is the most important and effective of all the elements of promotional
mix in pharmaceutical marketing. It can increase awareness, create interest,
lead the doctors to evaluate, induce them to try their products and after
successful trial persuade them to use and reassure them to use repeatedly.
Personal selling, to be effective, should have the support of advertising, sales
promotion and publicity. These other elements of the promotional mix create
a favourable climate and get the Medical representatives of a company the
much needed welcome at the enhance.
Doctors want more from pharmaceutical sales representatives than
just a quick sales pitch and drop-off of samples. They want a collaborative
relationship with sales representatives (medical representatives) as trusted
partners to gain access to relevant information and tools that will help their
practice. Developing a collaborative approach can result in increased access
to doctors and increased sales representative productivity.
94
In the pharma company, sales representatives are charged with
providing credible product information to doctors, in an increasingly
constrained environment, that is PhRMA (Pharmaceutical Researcher and
Manufacture Association) guidelines, reduced doctors’ access, increased
numbers of sales representatives and so on. The end result is that doctors are
spending less time with pharmaceutical sales representatives. (It is
applicable in specially US market) Whereas in India due to Fringe Benefit
Tax (FBT) and more number of Medical representatives visiting to the
doctors clinics, thereby doctors are frustrated (some times) and reduce their
interview times with pharmaceutical Medical Representatives.
However, doctors, as prescription gatekeepers, have historically been
the primary audience for pharmaceutical companies. This role has been
eroded by ongoing changes in how health care is paid for and who
influences, and to what degree they influence prescribing decisions. We put
this issue to the think tank, since it is reasonable to address it as a first step
in thinking about investing in doctor’s relationship.
The doctor's most direct point of contact with a pharmaceutical
company is the pharmaceutical sales representative medical representatives,
95
many of whom provide these types of benefits. It is reasonable, therefore, to
expect that the benefits gained from interacting with pharmaceutical sales
representatives would translate into doctors holding positive perceptions of
these representatives. However, any negative element in the customer-client
(doctors-representative) relationship lays the groundwork for negative
outcomes: refusal, denial, or passive aggression.
Because sales representatives are a significant source of information
in an area fraught with the potential for harmful consequences, it is
important for doctors to hold positive perceptions regarding a
pharmaceutical sales representative's drug, company, knowledge, values and
so on. These positive perceptions are necessary in order for the doctors to
see the information provided as being credible and to have confidence in
prescribing the drug.
3.6 RELATIONSHIP BETWEEN SENIOR MANAGER AND
DOCTORS
In pharma company senior managers' role are very vital in every
aspect. Moreover senior managers' visit will enhance the relationship with
their customer like Doctors. This relationship will satisfy the ego of doctors.
96
During last 10 years medical practitioners also have undergone
tremendous changes. They almost vacillated from professionalism to
commercialism. Pharmaceutical companies are also equally responsible for
making a number of small scale companies gullible. As many as 16,000
companies find their ways to reach practitioners in innovative ways. As a
result 40, 50, 60 brands try to find out individual ways to get the
prescriptions from these practitioners. After all survival is of the fittest. In
this context, if Pharma Company wants to succeed in their business they
must develop good relationship with their doctors. So relationship marketing
is very vital in pharma company. Pharmaceutical companies are adopting so
many strategies to develop good relationship with their customer. The
purpose of this research is to understand which factors really influence them
in the context of relationship marketing.
3.7 DIMENSION-WISE COMPARISON BETWEEN DOCTORS
AND MEDICAL REPRESENTATIVES PERCEPTION ON
RELATIONSHIP WITH PHARMA COMPANY
Doctor relationship marketing is the establishment and enhancement
of mutually beneficial long-term relationships between the Doctor and
Organizations.
97
Pharmaceutical Promotional Mix
The promotional mix in pharmaceutical marketing includes personal
selling, advertising, sales promotion and publicity. These can be further
segmented for the purpose of better understanding,
(i) Personal Selling: Medical sales representative or Medical
representatives detail the company’s product to doctors, with the help of
visual aids, leave- behind-literature, product monographs, samples, gifts, etc.
which are the most important elements of pharmaceuticals promotion.
(ii) Advertising: Preparation of visual aids, leave-behind-literature,
product monographs to assist medical sales representatives in their detailing
efforts, and advertising their products in specialized media like medical
journals and souvenirs, seminars and medical symposia and mailers for
doctor.
(iii) Sales Promotion: Deciding on special bonus offers, free samples,
gifts and sponsorship.
98
(iv) Publicity: Organizing medical symposia and seminars,
conducting clinical trials, conducting exhibitions, designing and executing
product publicity campaigns for truly innovative products.
All these pharmaceutical promotional mix come under seven
dimensions under three major factors which will influence the doctors to
have relationship with pharmaceutical company. These are:
Human factors
Product factors
Service factor
Human Factors Product Factors Service
1. Medical representatives 1. Product Quality 1. Scientific Support
2. Senior Managers' Role 2. Product Price 2. Sponsorship
3. Company image
This section analyses the various dimensions namely role of Medical
representatives and senior manages under Human Factors, product quality,
product price and company image under product factor, and Scientific
support and sponsorship under service factors which influence the doctors
relationship with pharma company in the study region. For this, personal
interview method was adopted with a well designed comprehensive schedule
that constitutes the statements under each dimension identified for the study.
99
3.7.1 Relationship of the Perception of Doctors Relation with Pharma
Company Between Doctors and Medical representatives
Table 3.1 clearly exhibits the relationship between doctors and
Medical representatives regarding the components under the dimensions of
product factors.
TABLE 3.1
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION COMPONENTS
UNDER PRODUCT FACTOR
Sl.
No.
Components of Product
Factors
Doctors Medical
Representative
Mean
score
Rank Mean
score
Rank
1. Quality of Product 4.58 I 4.63 I
2. Product Faster Resolution 4.24 II 4.32 II
3. Product Dosage Convenience 2.78 V 3.79 III
4. Product Acceptance by Patients 3.87 III 3.28 IV
5. Product Side effects 3.16 IV 2.25 VI
6. Product strength 2.41 VI 2.34 VII
7. Product delivery system 2.12 VII 2.77 V
Source: Primary data.
100
The analysis of data in Table 3.1 clearly indicates that both the
doctors and Medical representatives are having the same perception
regarding concern of quality of product and product faster resolution. These
factors were ranked first and second respectively by doctors and Medical
Representatives under the dimension of product factors. The other factors
namely product acceptance by patients, product side effects, Dosage
convenience of the product, product strength and product delivery system
are ranked third, fourth, fifth, sixth and seventh respectively by the doctors.
Medical representatives ranked these factors in fourth, sixth, third, seventh
and fifth place respectively.
In order to examine the agreement in perception between doctors and
Medical representatives regarding their perception, spearman's rank
co-efficient has been computed. The computed result (R = 0.75 P < 0.012)
showed that both doctors and Medical representatives are having the same
perception regarding the factors under product factors.
The relationship between doctors and Medical representatives in the
perception of components under product price is presented in the following
Table 3.2.
101
TABLE 3.2
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF COMPONENTS
UNDER PRODUCT PRICE
Sl.
No.Components of Product Price
DoctorsMedical
Representatives
Mean
scoreRank
Mean
scoreRank
1. Premium Price 2.12 V 1.83 V
2. Moderate Price 4.41 I 2.41 IV
3. Economical Price 3.98 II 4.37 I
4. Product packing size 3.27 III 3.80 II
5. Product Presentation Look 2.79 IV 2.82 III
Source: Primary data.
It is understood from Table 3.2 that both the doctors and Medical
Representatives have slightly differed in their perception regarding the
different components under product price. The components namely:
moderate price, economical price, product packing size, product presentation
look and premium price are ranked first, second, third, fourth and fifth
respectively by doctors. These components are ranked fourth, first, second,
third and fifth respectively by Medical Representatives.
102
The computed spearman rank correlation co-efficient (R=0.39,
P < 0.038) showed a poor relationship in perception between doctors and
Medical representatives regarding product price.
Table 3.3 indicates the relationship in perception between doctors and
Medical representatives regarding the components under company image.
TABLE 3.3
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF COMPONENTS
UNDER COMPANY IMAGE
Sl.
No.
Components of Company
Image
Doctors Medical
Representatives
Mean
score
Rank Mean
score
Rank
1. Multinational company 4.42 I 4.59 I
2. Large size Indian company 3.87 II 4.32 II
3. Medium size company 2.32 V 3.16 III
4. Research background 3.06 III 2.58 IV
5. Company image in the market
price
2.81 IV 1.78 V
Source: Primary data.
The results revealed that both the doctors and Medical representatives
are having the same perceptions regarding the components namely
103
multinational company and large size Indian companies under company
image. These components are ranked first and second by both doctors and
Medical Representatives. The other components under the dimension of
company image namely research background, medium size company and
company image in the market place are ranked third, fourth and fifth by
doctors. Medical Representatives ranked these components in fourth, third
and fifth place respectively.
The computed value of spearman's Rank correlation co-efficient
(R = 0.69, P < 0.016) indicates that both are having same perception
regarding the components under company image.
Table 3.4 shows the relationship between doctors and Medical
representatives in the perception regarding the components under the
dimensions of role of Medical Representatives.
104
TABLE 3.4
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF COMPONENTS
UNDER ROLE OF MEDICAL REPRESENTATIVES
Sl.
No.
Components of behaviour of
Medical Representatives
DoctorsMedical
Representatives
Mean
scoreRank
Mean
scoreRank
1. Common sense 4.08 II 3.97 III
2. Effective Communication 2.47 VI 4.07 II
3. Influencing ability 2.75 V 2.27 IX
4. Regular visit 4.39 I 4.52 I
5. Product knowledge 3.05 IV 3.40 V
6. Committed person 2.06 VIII 2.35 VIII
7. Time management 1.74 IX 2.24 X
8. Value system 2.12 VII 2.74 VII
9. The company he works for 1.72 X 3.16 VI
10. Sincerity 3.73 III 3.62 IV
Source: Primary data.
It is observed from Table 3.4 that both the doctors and Medical
Representatives are having same perceptions regarding the components
namely regular visit, value system and committed person under the
105
dimension of role of Medical Representatives. These components are
ranked first, seventh and eight place by both doctors and Medical
Representatives. The other components namely common sense, effective
communication, influencing ability, product knowledge, time management,
the company he works for and sincerity have been slightly different in
perception by both doctors and Medical Representatives.
The result of spearman's rank correlation co-efficient (R = 0.84
P < 0.001) indicates that there is a high relation in the perception level
between doctors and Medical Representatives regarding component under
the dimension of role of Medical Representatives.
Table 3.5 indicates the relation in the perception between doctors and
Medical Representatives regarding the components under the dimensions of
senior management personnel.
106
TABLE 3.5
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF COMPONENTS
UNDER SENIOR MANAGEMENT PERSONAL
Sl.
No.
Components of Senior
Management Personnel
DoctorsMedical
Representatives
Mean
scoreRank
Mean
scoreRank
1. Visiting Doctors Clinic 4.40 I 4.12 I
2. Fulfilling Doctors need in Time 4.24 II 3.17 II
3. Technical supports providing 3.14 III 3.04 III
4. Interacting frequently 2.68 IV 2.27 IV
5. Contact through phone 2.24 VI 1.81 V
6. Greetings during important days 2.01 V 1.79 VI
Source: Primary data.
The analysis revealed that both doctors and Medical Representatives
are having the same perception regarding concern of visiting doctors clinic,
fulfilling doctors need in time, technical supports providing and interacting
frequently under the dimensions of senior management personnel these
components are ranked first, second, third and fourth respectively by both
doctors and Medical Representatives. The other components namely
greetings during important days and contact through phone are ranked fifth
107
and sixth respectively by the doctors, Medical Representatives ranked these
components sixth and fifth place respectively.
The computed result of spearman rank correlation co-efficient
(R = 0.94, P < 0.016) showed the perfect perception regarding the dimension
of senior management personnel.
Table 3.6 indicates the relationship in perception regarding the
components under the dimension scientific factor.
TABLE 3.6
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF
COMPONENTS UNDER SCIENTIFIC FACTOR
Sl.
No.
Components of Scientific
Factor
DoctorsMedical
Representatives
Mean
scoreRank
Mean
scoreRank
1. Product sample 4.26 I 4.37 I
2. Offering Literature 3.51 III 3.61 III
3. Conducting CME / CMTE 2.22 VI 3.14 IV
4. Support for higher Education/
Research
2.44 V 2.91 V
5. Patient Education Programme 3.18 IV 2.66 VI
6. Offering Medical Journals /
Books
3.91 II 4.07 II
Source: Primary data.
108
It is clearly understood from Table 3.6 that both the doctors and
Medical representatives are having the same perception regarding the
components product sample, offering medical journals/books; and
supporting for higher education and research under the dimensions of
scientific factor. The components are ranked first, second, third and fifth by
both doctors and Medical representatives. The other components namely
patient education programme and conducting CME/CMTE are ranked fourth
and sixth respectively by the doctors. Medical representatives ranked these
components sixth and fourth place respectively.
The computed result of spearman's rank correlation co-efficient
(R=0.93 P < 0.004) showed the same perception regarding the components
under the dimension of scientific factor.
Relationship between doctors and Medical Representatives in the
perception level of components under the dimension namely sponsorship is
shown in Table 3.7.
109
TABLE 3.7
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF COMPONENTS
UNDER SPONSORSHIP
Sl.
No.Components of Sponsorship
DoctorsMedical
Representatives
Mean
score
Rank Mean
score
Rank
1. Sponsorship for clinical needs 4.58 I 4.18 I
2. Sponsorship for Indian
Association of Dermatologists,
Venereologists and
Leprologists (IADVL)
conference registration
4.23 II 4.06 II
3. Sponsorship for Indian
Association of Dermatologists,
Venereologists and
Leprologists (IADVL)
conference stay
2.56 IV 3.20 III
4. Sponsorship for Indian
Association of Dermatologists,
Venereologists and
Leprologists (IADVL)
conference travel
3.27 III 2.79 IV
5. Sponsorship for family
members
2.35 V 2.40 V
6. Sponsorship for International
conference
2.01 VI 2.21 VI
7. Sponsorship for value gifts 1.78 VII 2.10 VII
Source: Primary data.
110
It is inferred from Table 3.7 that both the doctors and Medical
representatives are having the same perceptions regarding, concern of
sponsorship for clinical needs, sponsorship for Indian Association of
Dermatologists, Venereologists and Leprologists (IADVL) conference
registration, sponsorship for family members, sponsorship for international
conference and sponsorship for value gifts under sponsorship. These
components are ranked first, second, fifth, sixth and seventh respectively by
both. The other components namely sponsorship for travel and sponsorship
for IADVL conference stay are ranked third and fourth respectively by the
doctors. Medical Representatives ranked these components fourth and third
respectively.
The Spearman's rank correlation co-efficients (R = 0.44, P < 0.018)
indicated a perfect equal, perception regarding the components under
sponsorship.
Dimension wise comparisons in the perception level are given in
Table 3.8.
111
TABLE 3.8
RELATIONSHIP BETWEEN DOCTORS AND MEDICAL
REPRESENTATIVES IN THE PERCEPTION OF DIFFERENT
DIMENSIONS
Sl.
No. Factors
Doctors Medical
Representatives InferenceScore
value
Rank Score
value
Rank
I. Product Factors
1. Product Factors 3.24 II 3.42 II Similar
2. Product Price 2.41 VI 2.18 VII Slight difference
3. Company Image 2.34 VII 2.38 V Slight difference
II. Human Factors
4. Role of Medical
Representatives
4.11 I 4.71 I Similar
5. Senior Managers Role 2.68 V 2.33 VI Slight difference
III. Service Factors
6. Scientific factor 2.81 IV 2.95 IV Similar
7. Sponsorship 3.01 III 3.11 III Similar
It is observed from Table 3.8 that the perception levels of both doctors
and Medical Representatives are similar in majority of the dimensions
namely role of Medical Representatives, product factors, sponsorship and
scientific factor. A slight difference in perceptions was observed in other
dimensions namely product price, senior managers and company image.
Thus, it may be concluded from the analysis that both doctors and Medical
Representatives are having the similar perception in relationship marketing
between the doctors and Pharma Company in the study regions.